Standard BioTools Inc. 2026 Change of Control and Severance Plan

Standard BioTools Inc. has established the 2026 Change of Control and Severance Plan, effective May 21, 2026, with a term until August 4, 2028. This plan is designed to provide severance payments and other benefits to eligible executive leadership team members and designated employees upon qualifying termination of employment, excluding the CEO who is under the 2023 plan. The plan outlines different severance packages depending on whether the termination occurs outside or during a "Change of Control Period." Benefits include continued base salary payments, pro-rated target bonus payments, continued health coverage, and accelerated vesting of equity awards. Specific provisions are made for terminations due to reasons other than Cause, death, or Disability, and for terminations within the Change of Control Period, which may include enhanced benefits such as a larger lump-sum payment and longer health coverage continuation. The plan also details conditions for eligibility, including signing a release agreement, and addresses limitations on payments to comply with Section 409A of the Code. The 2026 Severance Plan supersedes previous agreements for participating employees, including Alex Kim (CFO) and Sean Mackay (CBO), who have entered into participation agreements.